A WONDER drug which targets a faulty gene stops the spread of prostate cancer, a trial has shown.
Olaparib offers hope to 4,000 British men in the advanced stages of the disease.
It is already used for women, such as actress Angelina Jolie, who are at greater risk of breast cancer from the BRCA gene mutation.
Now, early results from British drugs giant AstraZeneca reveal it halted the spread of tumours in 387 men with advanced prostate cancer.
Read more from Nick McDermott’s article here: https://www.thesun.co.uk/news/9676796/drug-stops-prostate-cancer-spreading/